Impact of glucocorticoids on the therapeutic efficacy of denosumab against osteoporosis in patients with rheumatoid arthritis
Background: Rheumatoid arthritis (RA) and prolonged high-dose glucocorticoid (GC) treatment are established risk factors for osteoporosis. Objectives: In this study, we aimed to evaluate the therapeutic efficacy of denosumab according to the GC dose considered to increase the risk of glucocorticoid-...
Saved in:
Main Authors: | Jiwon Yang, Youngjae Park, Jennifer Jooha Lee, Seung-Ki Kwok, Ji Hyeon Ju, Wan-Uk Kim, Sung-Hwan Park |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Musculoskeletal Disease |
Online Access: | https://doi.org/10.1177/1759720X251314712 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus
by: Sung-Hwan Park, et al.
Published: (2025-01-01) -
The prevalence, clinical features, and long-term outcome of patients with primary Sjögren’s syndrome with renal involvement
by: Howook Jeon, et al.
Published: (2025-02-01) -
Diabetes Is Associated with Musculoskeletal Pain, Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis
by: Thomas Rehling, et al.
Published: (2019-01-01) -
The Characteristics and Mortality of Osteoporosis, Osteomyelitis, or Rheumatoid Arthritis in the Diabetes Population: A Retrospective Study
by: Jin-Feng Huang, et al.
Published: (2020-01-01) -
siRNA therapeutics for effective management of rheumatoid arthritis
by: Vishakha R. Chakole, et al.
Published: (2025-01-01)